Further discussion on glucocorticoid treatment of COVID-19
Chin Med J (Engl)
.
2022 Jun 5;135(11):1386.
doi: 10.1097/CM9.0000000000001872.
Authors
Yun'ai Feng
1
,
Haichao Li
Affiliation
1
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
PMID:
36044381
PMCID:
PMC9433069
DOI:
10.1097/CM9.0000000000001872
No abstract available
MeSH terms
COVID-19 Drug Treatment*
Glucocorticoids / therapeutic use
Humans
SARS-CoV-2
Substances
Glucocorticoids